Lunai Bioworks receives first LOI to license next-generation immune cell therapy

Novo Nordisk reports strong phase 2 results for amycretin in type 2 diabetes

Active Biotech to receive US patent for tasquinimod formulation

Sanofi and Regeneron's Dupixent approved in EU for chronic spontaneous urticaria

Blacksmith Medicines granted European patent for LpxC-targeting antibacterial compounds

Xenogenic Materials Demonstrate Promising Results in Peri-Implantitis Management

LivaNova secures higher Medicare reimbursement for VNS Therapy procedures

AstraZeneca to invest USD2bn in major Maryland manufacturing expansion

Riyadh's 10th SPNS Conference Focuses on AI and Technology as Catalysts for Better Paediatric Neurology Care

Vaximm enters non-binding term sheet with BCM Europe

Flagship Pioneering announces new agreements with ProFound Therapeutics and Quotient Therapeutics under GSK collaboration

Abbott agrees to acquire Exact Sciences

Nuvalent's zidesamtinib NDA filing accepted by US FDA

Innovent Biologics reports primary and all key secondary endpoints met in mazdutide Phase 3 trial

Hemispherian secures US patent allowance expanding GLIX1 patent protection